News
-
-
PRESS RELEASE
The FDA's approval of Fermentalg's natural blue dye paves the way for a new generation of bio-based products in the food industry.
Fermentalg's Everzure™ Galdieria, a natural blue dye approved by the FDA, offers innovative biosourced solution for food industry, replacing petroleum-based colorants -
PRESS RELEASE
Klea Holding mark strong start to Q2 2025 with new monthly record in April for its subsidiary Smart Salem
Smart Salem, a subsidiary of Klea Holding, achieves a new monthly record by conducting 18,497 tests in April 2025, displaying a 94% year-on-year growth. Growth strategy in progress -
-
PRESS RELEASE
Solid growth in the cloud // Pinnacle Award 2025 // Geopolitical environment leads to project delays despite strong pipeline // Forecast confirmed
All for One Group SE reports solid growth in cloud services despite geopolitical challenges causing project delays. Unaudited results show sales at EUR 257.6 million and dividend increased to EUR 1.60 per share. Forecast for 2024/25 confirmed -
PRESS RELEASE
AEVIS VICTORIA SA – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025.
AEVIS VICTORIA SA reports 17.0% revenue growth in Q1 2025, driven by Swiss Medical Network and MRH Switzerland AG. Expansion and acquisitions support momentum -
PRESS RELEASE
Newron announces approval for pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
Newron Pharmaceuticals announces approval for pivotal Phase III ENIGMA-TRS program evaluating evenamide as add-on therapy in treatment-resistant schizophrenia patients. Study results expected in Q4 2026 -
-
-
